(E)-3-thiophen-2-ylprop-2-enoyl azide | 119924-27-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: (E)-3-thiophen-2-ylprop-2-enoyl azide
• CAS: 119924-27-5
• 化学式: C₇H₅N₃OS
• 分子量: 179.202
• InChiKey: RKEBIPZECWLWHD-ONEGZZNKSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  59.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-3-thiophen-2-ylprop-2-enoyl azide 在 sodium 2-ethylhexanoic acid 作用下， 以 甲苯 为溶剂， 反应 19.0h， 生成
  参考文献：
  名称：

  Synthesis and evaluation of ureido and vinylureidopenicillins as inhibitors of intraruminal lactic acid production

  摘要：

  A series of 14 vinylureidopenicillins and a series of 9 ureidopenicillins were prepared by reaction of 6-aminopenicillanic acid with vinyl isocyanates and isocyanates. These compounds were evaluated for their potential to protect ruminants against lactic acidosis. The compounds were tested for inhibition of in vitro ruminal lactic and propionic acid production, and six compounds inhibited lactic acid production to less than 10% of control at doses of 0.31 microgram/mL or lower, whereas they did not inhibit propionic acid production at doses greater than 10 micrograms/mL. The most active compounds also were screened for general antibacterial activity and were found to be weakly active against Gram-positive bacteria. The structure--activity relationships are discussed for both series. Triethylammonium 6-[3[2-(4-tert-butylphenyl)vinyl]ureido]penicillanate (4) was chosen for evaluation as an inhibitor of intraruminal lactic acidosis in vivo.

  DOI：

  10.1021/jm00142a024
• 作为产物：
  描述：

  (2E)-3-(2-噻吩基)丙烯酰氯 在 sodium azide 作用下， 以 水 为溶剂， 反应 1.0h， 生成 (E)-3-thiophen-2-ylprop-2-enoyl azide
  参考文献：
  名称：

  Synthesis and evaluation of ureido and vinylureidopenicillins as inhibitors of intraruminal lactic acid production

  摘要：

  A series of 14 vinylureidopenicillins and a series of 9 ureidopenicillins were prepared by reaction of 6-aminopenicillanic acid with vinyl isocyanates and isocyanates. These compounds were evaluated for their potential to protect ruminants against lactic acidosis. The compounds were tested for inhibition of in vitro ruminal lactic and propionic acid production, and six compounds inhibited lactic acid production to less than 10% of control at doses of 0.31 microgram/mL or lower, whereas they did not inhibit propionic acid production at doses greater than 10 micrograms/mL. The most active compounds also were screened for general antibacterial activity and were found to be weakly active against Gram-positive bacteria. The structure--activity relationships are discussed for both series. Triethylammonium 6-[3[2-(4-tert-butylphenyl)vinyl]ureido]penicillanate (4) was chosen for evaluation as an inhibitor of intraruminal lactic acidosis in vivo.

  DOI：

  10.1021/jm00142a024

文献信息

• Organic metal compound and organic light-emitting device
  申请人：INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE

  公开号：US20200024294A1

  公开（公告）日：2020-01-23

  Organic metal compounds and organic light-emitting devices employing the same are provided. The organic metal compound has a chemical structure of Formula (I) or Formula (II): In particular, one of the following two conditions (1) and (2) is met: ( 1 ) R 1 is deuterium or C 1-6 deuterated alkyl group, when R 3 and R 4 are independently hydrogen, halogen, C 1-6 alkyl group, C 1-6 fluoroalkyl or C 3-12 heteroaryl group; and (2) R 1 is hydrogen, deuterium, C 1-6 alkyl group, C 1-6 deuterated alkyl group, C 3-12 heteroaryl group, or C 6-12 aryl group, when at least one of R 3 and R 4 is C 6-12 aryl group or C 6-12 fluoroaryl group.

  提供有机金属化合物和利用这些化合物的有机发光器件。有机金属化合物具有化学结构的公式(I)或公式(II)：具体地，满足以下两种条件之一(1)和(2)：(1) R1为氘或C1-6氘代烷基，当R3和R4分别为氢、卤素、C1-6烷基、C1-6氟烷基或C3-12杂芳基时；以及(2) R1为氢、氘、C1-6烷基、C1-6氘代烷基、C3-12杂芳基或C6-12芳基，当R3和R4中至少有一个为C6-12芳基或C6-12氟芳基时。
• AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE
  申请人：Borchardt Allen J.

  公开号：US20100063047A1

  公开（公告）日：2010-03-11

  The present invention relates to compounds and methods which may be useful as inhibitors of H 1 R and/or H 4 R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.

  本发明涉及化合物和方法，可能作为H1R和/或H4R的抑制剂用于治疗或预防炎症性、自身免疫性、过敏性和眼部疾病。
• 10.1021/acs.orglett.4c01403
  作者：Zhu, Gongming、Zhang, Haiyang、Han, Liyang、Wang, Honglei、Zhu, Anlian、Li, Lingjun

  DOI：10.1021/acs.orglett.4c01403

  日期：——

  The intramolecular Curtius rearrangement suffers from a high reaction temperature, low yields, tedious product isolation, and difficult scale up. This study presents a room-temperature Curtius rearrangement that can be novelly driven by the HFIP solvent, followed by light-illuminated intramolecular cyclization. Such a mild reaction allows for the preparation of various fused pyridone derivatives with

  分子内Curtius重排反应温度高、产率低、产物分离繁琐且难以放大。这项研究提出了一种可以由 HFIP 溶剂驱动的室温 Curtius 重排，然后进行光照射分子内环化。这种温和的反应允许制备具有不同取代基的各种稠合吡啶酮衍生物，这些取代基很少被以前的方法掺入。通过结合 IR 和 NMR 滴定的一组对照实验研究了 HFIP 和光的作用。此外，使用取代的融合吡啶酮作为非天然碱基，我们可以获得一组新的核苷酸。
• Trimethylsilyl azide-promoted acid-amine coupling: A facile one-pot route to amides from carboxylic acids and amines
  作者：Yellaiah Tangella、Jay Prakash Soni、Nagula Shankaraiah、Diana Abril、Manda Sathish

  DOI：10.24820/ark.5550190.p011.914

  日期：——
• [EN] AMINOPYRIMIDINE INHIBITORS OF HISTAMINE RECEPTORS FOR THE TREATMENT OF DISEASE<br/>[FR] INHIBITEURS AMINOPYRIMIDINE DES RÉCEPTEURS DE L'HISTAMINE DESTINÉS AU TRAITEMENT D'UNE MALADIE
  申请人：KALYPSYS INC

  公开号：WO2010030757A2

  公开（公告）日：2010-03-18

  The present invention relates to compounds and methods which may be useful as inhibitors of HiR and/or H4R for the treatment or prevention of inflammatory, autoimmune, allergic, and ocular diseases.